Status:
COMPLETED
Inpatient Smokers and LDCT Screening RCT
Lead Sponsor:
Boston University
Collaborating Sponsors:
American Lung Association
Conditions:
Lung Cancer
Shared Decision Making
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
Current smokers who undergo annual low dose CT (LDCT) lung cancer screening and successfully quit smoking derive the greatest reduction in lung cancer mortality. Unfortunately, those at highest risk o...
Detailed Description
The goal of this study is to create and evaluate an intervention that capitalizes on hospitalization at an urban safety net hospital as an opportunity to connect high risk smokers to lung cancer scree...
Eligibility Criteria
Inclusion
- hospitalized smokers at BMC meeting LDCT screening eligible criteria
- males and females 55-80 years of age
- ≥30-pack years smoking
- current smoker
- able to speak, read, and understand English
- able and willing to participate and provide informed consent
Exclusion
- severe co-morbidities expected to limit life expectancy or ability to tolerate surgical resection of a lung cancer, including patients requiring home oxygen therapy (an indicator of severe lung or heart disease), and patients with active cancer
- patients who have already had LDCT screening in the past year
Key Trial Info
Start Date :
November 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT03276806
Start Date
November 7 2017
End Date
July 1 2019
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118